A higher number of CD8+ T cell, macrophages M1, cases were positively associated with better OS and DFS in HCC patients, whereas macrophages M2 were related to a poor prognosis and outcome of HCC (56–59). Here, CD8A is linked to hepatocellular carcinoma.